Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
Fidelity Healthy Future FAPHX
- NAV / 1-Day Return 13.52 / −0.22 %
- Total Assets 12.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.050%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Large Growth
- Investment Style Large Growth
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.10%
- Turnover 68%
USD | NAV as of Sep 26, 2024 | 1-Day Return as of Sep 26, 2024, 4:34 AM GMT+0
Morningstar’s Analysis FAPHX
Will FAPHX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 45.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
NVIDIA Corp | 8.17 | 960,734 | Technology |
Procter & Gamble Co | 6.23 | 732,262 | Consumer Defensive |
Tesla Inc | 5.04 | 592,011 | Consumer Cyclical |
Thermo Fisher Scientific Inc | 4.54 | 533,606 | Healthcare |
Vertex Pharmaceuticals Inc | 3.97 | 466,968 | Healthcare |
UnitedHealth Group Inc | 3.74 | 439,610 | Healthcare |
Regeneron Pharmaceuticals Inc | 3.73 | 438,151 | Healthcare |
Danaher Corp | 3.44 | 404,260 | Healthcare |
Nestle SA | 3.43 | 403,043 | Consumer Defensive |
Colgate-Palmolive Co | 2.95 | 346,272 | Consumer Defensive |